IRIS
CHITI, ARTURO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 14.086
AS - Asia 4.406
EU - Europa 2.294
SA - Sud America 1.098
AF - Africa 424
Continente sconosciuto - Info sul continente non disponibili 14
OC - Oceania 9
Totale 22.331
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 13.821
SG - Singapore 2.621
BR - Brasile 956
CN - Cina 948
FI - Finlandia 549
IE - Irlanda 399
NG - Nigeria 349
DE - Germania 287
IT - Italia 224
CA - Canada 199
FR - Francia 180
IN - India 161
VN - Vietnam 159
GB - Regno Unito 139
HK - Hong Kong 137
SE - Svezia 135
NL - Olanda 126
TR - Turchia 101
RU - Federazione Russa 62
IL - Israele 59
BE - Belgio 57
AR - Argentina 55
BD - Bangladesh 40
MX - Messico 36
IQ - Iraq 32
ZA - Sudafrica 31
PL - Polonia 26
EC - Ecuador 24
ES - Italia 22
JP - Giappone 21
ID - Indonesia 15
CL - Cile 14
CO - Colombia 14
UA - Ucraina 14
AT - Austria 13
IR - Iran 13
MA - Marocco 12
SA - Arabia Saudita 12
AE - Emirati Arabi Uniti 11
CZ - Repubblica Ceca 10
JM - Giamaica 9
KE - Kenya 9
KG - Kirghizistan 9
PE - Perù 9
PK - Pakistan 9
EU - Europa 8
PY - Paraguay 8
TW - Taiwan 8
UY - Uruguay 8
EG - Egitto 7
KZ - Kazakistan 7
UZ - Uzbekistan 7
VE - Venezuela 7
TN - Tunisia 6
AU - Australia 5
EE - Estonia 5
JO - Giordania 5
LT - Lituania 5
NP - Nepal 5
PA - Panama 5
RO - Romania 5
CH - Svizzera 4
GT - Guatemala 4
NZ - Nuova Zelanda 4
A2 - ???statistics.table.value.countryCode.A2??? 3
BG - Bulgaria 3
DO - Repubblica Dominicana 3
HR - Croazia 3
MT - Malta 3
MY - Malesia 3
NI - Nicaragua 3
PH - Filippine 3
TH - Thailandia 3
XK - ???statistics.table.value.countryCode.XK??? 3
AL - Albania 2
AM - Armenia 2
AO - Angola 2
AZ - Azerbaigian 2
BO - Bolivia 2
BY - Bielorussia 2
GR - Grecia 2
HN - Honduras 2
KR - Corea 2
LA - Repubblica Popolare Democratica del Laos 2
LB - Libano 2
LU - Lussemburgo 2
LV - Lettonia 2
NO - Norvegia 2
OM - Oman 2
PS - Palestinian Territory 2
SC - Seychelles 2
SK - Slovacchia (Repubblica Slovacca) 2
CI - Costa d'Avorio 1
CR - Costa Rica 1
DK - Danimarca 1
DM - Dominica 1
DZ - Algeria 1
ET - Etiopia 1
GA - Gabon 1
GI - Gibilterra 1
Totale 22.316
Salva come PNG Salva come JPEG
Città #
Dallas 2.222
Wilmington 2.010
Chandler 1.882
Singapore 836
San Mateo 776
The Dalles 701
Ann Arbor 609
Helsinki 545
Shanghai 529
Ashburn 448
Leawood 401
Dublin 398
Boardman 356
Benin City 348
Lawrence 327
Princeton 327
Beijing 226
New York 211
Fairfield 195
Woodbridge 181
Toronto 169
Paris 163
Amsterdam 114
Hong Kong 111
Pune 97
São Paulo 85
London 82
Kocaeli 80
Milan 79
Seattle 75
Los Angeles 69
Ho Chi Minh City 61
San Diego 57
Brussels 56
Santa Clara 53
Norwalk 49
Monmouth Junction 44
Rio de Janeiro 38
Munich 35
Council Bluffs 34
Brooklyn 31
Moscow 31
Phoenix 31
Falls Church 30
Hanoi 30
Houston 23
Belo Horizonte 22
Warsaw 22
Johannesburg 20
Campinas 18
Atlanta 17
Chennai 15
Redmond 15
San Francisco 15
Stockholm 15
Brasília 14
Redwood City 14
Tokyo 14
Boston 13
Dhaka 13
Montreal 13
Orem 13
Osasco 13
Porto Alegre 13
Chicago 12
Curitiba 12
Goiânia 12
Cambridge 11
Denver 11
Falkenstein 11
Guarulhos 11
Des Moines 10
Mexico City 10
Mumbai 10
Naples 10
Zhengzhou 10
Berlin 9
Columbus 9
Da Nang 9
Fortaleza 9
Poplar 9
Tappahannock 9
Ankara 8
Baghdad 8
Bishkek 8
Düsseldorf 8
Erbil 8
Guayaquil 8
Kingston 8
Ribeirão Preto 8
Terracina 8
Vienna 8
Abbiategrasso 7
Andover 7
Brno 7
Camaçari 7
Charlotte 7
Florence 7
Hải Dương 7
Joinville 7
Totale 15.854
Salva come PNG Salva come JPEG
Nome #
11C-Choline-Pet Guided Stereotactic Body Radiation Therapy for Lymph Node Metastases in Oligometastatic Prostate Cancer. 610
111In-octreotide uptake in granulomatous and tumor lesions in a patient with small-cell lung cancer 589
111In-DTPA-D-Phe-1-octreotide scintigraphy of small cell lung cancer. 571
11Cl-choline PET/CT in imaging locally advanced prostate cancer 557
18F-FDG PET and CT scan in the pre-operative evaluation of colorectal liver metastases treated with chemotherapy 135
18F-FDG pet does not improve contrast enhanced CT scan sensitivity in the evaluation of liver metastases after chemotherapy 130
Carbon-11-methionine PET-CT as an imaging biomarker in brain gliomas eligible for surgery 107
68GA-PSMA PET/CT FOR PRIMARY DIAGNOSIS OF PROSTATE CANCER IN MEN WITH CONTRAINDICATIONS TO OR NEGATIVE MRI: A PROSPECTIVE OBSERVATIONAL STUDY 106
Applications of PET imaging with radiolabelled choline (C-11/F-18-choline) 105
Ability of FDG PET and CT radiomics features to differentiate between primary and metastatic lung lesions 100
Are three weeks hypofractionated radiation therapy (HFRT) comparable to six weeks for newly diagnosed glioblastoma patients? Results of a phase II study 99
A case of metastatic axillary lymph nodes involvement from unknown primary cancer: Clinical usefulness of [Tc-99m]-sestamibi 97
A portrait of the scientist as a young woman Comments after the first EANM Young Investigators' Meeting 96
[F-18] FDG PET/CT features for the molecular characterization of primary breast tumors 96
arallel comparison of 68Ga-Prostate Specific Membrane Antigen PET-CT and PRIMUS in primary prostate cancer diagnosis 94
Advanced Imaging Supports the Mechanistic Role of Autoimmunity and Plaque Rupture in COVID-19 Heart Involvement 92
Positron emission tomography response at the time of autologous stem cell transplantation predicts outcome of patients with relapsed and/or refractory Hodgkin's lymphoma responding to prior salvage therapy 89
Ga-68-PSMA Positron Emission Tomography/Computerized Tomography for Primary Diagnosis of Prostate Cancer in Men with Contraindications to or Negative Multiparametric Magnetic Resonance Imaging: A Prospective Observational Study 88
Correlation of microvascular fractal dimension with positron emission tomography [C-11]-methionine uptake in glioblastoma multiforme: Preliminary findings 85
Prediction of disease-free survival by the PET/CT radiomic signature in non-small cell lung cancer patients undergoing surgery 85
Utility of 18F-FDG PET and contrast-enhanced CT scan in the assessment of residual liver metastasis from colorectal cancer following adjuvant chemotherapy 85
A risk management approach for imaging biomarker-driven clinical trials in oncology 84
A DOUBTFUL IMAGE OF LEVEEN SHUNT PATENCY 83
[18F]FDG PET/CT in Large Vessel Vasculitis: The Impact of Expertise and Confounders on Image Analysis 82
Application of Convolutional Neural Networks is promising in the definition of T-stage in lung cancer 82
Guideline for PET/CT imaging of neuroendocrine neoplasms with Ga-68-DOTA-conjugated somatostatin receptor targeting peptides and F-18-DOPA 81
A case of atypical giant cell arteritis diagnosed by positron emission tomography (PET) 81
INDIUM-111-DTPA-OCTREOTIDE SCINTIGRAPHY MODULATION BY TREATMENT WITH UNLABELED SOMATOSTATIN ANALOG IN SMALL-CELL LUNG-CANCER 80
C-11-Methionine uptake in secondary brain epilepsy 80
F-18-DOPA PET/CT in Neuroblastoma Comparison of Conventional Imaging With CT/MR 80
I-131/I-123-Metaiodobenzylguanidine (mIBG) scintigraphy: procedure guidelines for tumour imaging 80
Computed tomography based radiomic signature as predictive of survival and local control after stereotactic body radiation therapy in pancreatic carcinoma 80
Diffusion-weighted imaging and loco-regional N staging of patients with colorectal liver metastases 79
Positron Emission Tomography-Computed Tomography for Patients with Recurrent Colorectal Liver Metastases: Impact on Restaging and Treatment Planning 79
Imaging of neuroendocrine tumours with gamma-emitting radiopharmaceuticals 78
Radioiodine ablation with 1,850 MBq in association with rhTSH in patients with differentiated thyroid cancer 78
PREDICTIVE VALUE OF EARLY PET DURING SALVAGE CHEMOTHERAPY IN RELAPSING/REFRACTORY HODGKIN'S LYMPHOMA (HL) PATIENTS 78
Ga-68-PSMA PET/CT for primary diagnosis of prostate cancer in men with contraindications to or negative mpMRI 77
Computed tomography (CT)-derived radiomic features differentiate prevascular mediastinum masses as thymic neoplasms versus lymphomas 77
Axillary lymph node metastases detection with nuclear medicine approaches in patients with newly diagnosed breast cancer: Can positron emission tomography (PET) with F-18-FDG be considered as the best method? 76
A method to reduce acetonitrile amount in F-18-FDG synthesis 76
Prospective evaluation of Ga-68-PSMA PET/CT in primary prostate cancer diagnosis - final results of a dedicated trial 76
[C-11] Choline PET/CT Impacts Treatment Decision Making in Patients With Prostate Cancer Referred for Radiotherapy 76
Diagnostic accuracy of C-11-choline PET/CT in comparison with CT and/or MRI in patients with hepatocellular carcinoma 76
Evaluation of response: is F-18-FDG PET the answer? 75
Role of I-131-metaiodobenzylguanidine (MIBG) in the treatment of neuroendocrine tumours - Experience of the National Cancer Institute of Milan 75
Convolutional Neural Networks Promising in Lung Cancer T-Parameter Assessment on Baseline FDG-PET/CT 75
Prognostic value of molecular and imaging biomarkers in patients with supratentorial glioma 75
Chest CT in patients with a moderate or high pretest probability of COVID-19 and negative swab 75
Radiation dosimetry is a necessary ingredient for a perfectly mixed molecular radiotherapy cocktail 74
Bone lesion in a patient with transplanted liver for a metastatic carcinoid. The role of somatostatin receptor scintigraphy 74
Baseline FDG-PET/CT Radiomics to Predict Outcome in Lung Cancer Patients Treated with Surgery 74
[F-18]FDG PET/CT in non-union: improving the diagnostic performances by using both PET and CT criteria 74
FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0 74
Pancreatic cancer or chronic pancreatitis? An answer from PET/MRI image fusion 73
The 2015 Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma: the "evidence-based" refusal to endorse them by EANM due to the "not evidence-based" marginalization of the role of Nuclear Medicine 73
Prognostic significance of molecular and imaging biomarkers in primary brain tumors 73
Value of FDG-PET/CT radiomic features in predicting response to anti-programmed death 1 (PD-1) antibodies treatment in refractory Hodgkin Lymphoma patients 73
Clinical implications of immunohistochemical assessment of somatostatin receptors subtype 2 and 5 in the diagnostic and therapeutic management of gastro-entero-pancreatic neuroendocrine tumours 73
FDG-PET as a tool to optimize residual surgery in patients with primary extragonadal germ cell tumors: preliminary results 72
EANM 2012 guidelines for radionuclide imaging of phaeochromocytoma and paraganglioma 72
Assessment of tumor response in malignant pleural mesothelioma 71
PET/CT imaging for target volume delineation in curative intent radiotherapy of non-small cell lung cancer: IAEA consensus report 2014 71
48P The relationship among bowel FDG-PET uptake, pathological complete response, and the influence of eating and exercise habits in breast cancer patients undergoing neoadjuvant chemotherapy 70
Radiopharmaceuticals for breast cancer imaging 70
The Path to the Future: Education of Nuclear Medicine Therapeutic Specialists as Responsible Physicians 70
Re: Nicolas Mottet, Joaquim Bellmunt, Michel Bolla, et al. EAU Guidelines on Prostate Cancer. Part II: Treatment of Advanced, Relapsing, and Castration-Resistant Prostate Cancer. Eur Urol 2011;59:572-83 70
Multimodal Characterization of Supratentorial Gliomas: Relationship Among Morphological, Metabolic and Molecular features 70
Molecular Imaging in Radiotherapy Planning for Head and Neck Tumors 70
C-11-labeled methionine and evaluation of malignant pleural mesothelioma 69
Procedure guidelines for PET/CT tumour imaging with Ga-68-DOTA-conjugated peptides: Ga-68-DOTA-TOC, Ga-68-DOTA-NOC, Ga-68-DOTA-TATE 69
Assessment of mediastinal involvement in lung cancer with technetium-99m-sestamibi SPECT 69
EANM/EARL FDG-PET/CT accreditation - summary results from the first 200 accredited imaging systems 69
F-18-FDG PET/CT scans for children and adolescents 69
Utility of gallium-67 in determining the radicality of lymph node dissections of the neck for metastatic lymph nodes with extranodal spread in patients affected by carcinoma of the head and neck 69
Exploration of Disease Markers under Translational Medicine Model 68
Texture analysis and machine learning to characterize suspected thyroid nodules and differentiated thyroid cancer: Where do we stand? 68
F-18-FDG-PET (PET) and contrast-enhanced CT-scan (CT) in the evaluation of liver metastases from colorectal cancer after chemotherapy 68
Joint practice guidelines for radionuclide lymphoscintigraphy for sentinel node localization in oral/oropharyngeal squamous cell carcinoma 68
PET Radiomics in NSCLC: state of the art and a proposal for harmonization of methodology 67
New Clinical Indications for F-18/C-11-choline, New Tracers for Positron Emission Tomography and a Promising Hybrid Device for Prostate Cancer Staging: A Systematic Review of the Literature 67
Investigation on the role of integrated PET/MRI for target volume definition and radiotherapy planning in patients with high grade glioma 67
Allogeneic Stem Cell Transplantation (Allo-SCT) after Treatment with Programmed Cell Death-1 (PD-1) Checkpoint Inhibitors for Relapsed/Refractory Classic Hodgkin Lymphoma (R/R cHL) Is Associated with an Unprecedented Low Relapse Rate 67
SEGMENTAL FDG-PET/CT IN SOLITARY PULMONARY NODULE: PRELIMINARY DATA OF THE PET ITALIAN TRIAL 66
Prognostic and predictive role of [F-18]fluorodeoxyglucose positron emission tomography (FDG-PET) in patients with unresectable malignant pleural mesothelioma (MPM) treated with up-front pemetrexed-based chemotherapy 66
Consensus on molecular imaging and theranostics in prostate cancer 66
Early response evaluation in malignant pleural mesothelioma by positron emission tomography with [F-18]fluorodeoxyglucose 66
CASE-REPORT - TECHNETIUM-99M-HEXAKIS-2-METHOXY-ISOBUTYL-ISONITRILE IMAGING OF BREAST-CANCER AND MYOCARDIAL-INFARCTION IN THE SAME PATIENT 66
PET/CT radiomics in breast cancer: promising tool for prediction of pathological response to neoadjuvant chemotherapy 66
Targeted PET/TRUS software fusion‑guided biopsy in men with persistently elevated PSA and negative mpMRI after previous negative biopsy: A feasibility study and preliminary results 66
In-111-pentetreotide scintigraphy: procedure guidelines for tumour imaging 65
Role of C-11-choline PET/CT in radiation therapy planning of patients with prostate cancer 65
PRELIMINARY-RESULTS OF PREOPERATIVE AXILLARY RADIOIMMUNOSCINTIGRAPHY WITH IN-111 B72.3 IN BREAST-CANCER 65
The scintigraphy of somatostatin receptors in gastroenteropancreatic neuroendocrine tumors | [La scintigrafia dei recettori per la somatostatina nei tumori neuroendocrini gastro-entero-pancreatici.] 65
Standardization and quantification in PET/CT imaging: tracers beyond FDG. 65
Endorsement of International Consensus Radiochemistry Nomenclature Guidelines 65
Baseline Radiomic CT Features Differentiate Mediastinal Masses As Thymic Neoplasms Or Lymphomas 65
High-dose melphalan with autologous stem cell support in refractory Hodgkin lymphoma patients as a bridge to second transplant 65
HCC Radioembolization with Yttrium-90 Polymer Beads (SIR-Spheres):Tc-99m-MAA SPECT/CT based dosimetry correlation with survival and tumor response 65
PET/CT radiomics in breast cancer: Mind the step 65
Totale 9.717
Salva come PNG Salva come JPEG
Categoria #
all - tutte 166.172
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 166.172
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20213.702 0 0 0 0 0 1.227 544 278 734 501 38 380
2021/20221.919 161 17 62 414 37 28 73 260 161 129 486 91
2022/20235.106 748 197 462 560 456 462 10 410 947 432 344 78
2023/20242.627 220 320 583 174 63 301 150 129 51 35 240 361
2024/20253.436 90 71 28 42 62 431 195 380 435 888 414 400
2025/20265.499 1.383 759 1.977 918 281 181 0 0 0 0 0 0
Totale 22.496